Ariel Cohen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ariel Cohen has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- John David Spencer
Kidney and Urinary Tract Center, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, United States
2 shared publications - Amanda Castillo
Memorial Sloan Kettering Cancer Center, Department of Surgery, Gynecology Service, New York, NY, USA
1 shared publication Andrew L. Schwaderer
Center for Clinical and Translational Research, Department of Pediatrics, The Research Institute at Nationwide Children's, Columbus, Ohio, USA; Division of Nephrology, Department of Pediatrics, Nationwide Children's, Columbus, Ohio, USA
1 shared publicationBirong Li
Center for Clinical and Translational Research, Department of Pediatrics, The Research Institute at Nationwide Children's, Columbus, Ohio, USA
1 shared publicationBrian Becknell
Center for Clinical and Translational Research, Department of Pediatrics, The Research Institute at Nationwide Children's, Columbus, Ohio, USA; Division of Nephrology, Department of Pediatrics, Nationwide Children's, Columbus, Ohio, USA
1 shared publication- Christian Dagher
Memorial Sloan Kettering Cancer Center, Department of Surgery, Gynecology Service, New York, NY, USA
1 shared publication
Latest Publications
- 6 February 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (4) , 104562
Pre-operative imaging in clinical International Federation of Gynecology and Obstetrics stage IB2 or less cervical carcinoma
- 6 February 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (4) , 104562
Pre-operative imaging in clinical International Federation of Gynecology and Obstetrics stage IB2 or less cervical carcinoma
- 2 January 2026
- Published by Wiley in Sonography
- Vol. 13 (1)
Bladder Sonography as a Method of Diagnosing Gartner Cysts: A Case Report
Gartner cysts, also referred to as Gartner duct cysts, are congenital urogenital anomalies that result from failure of regression of the Wolffian ducts. These cysts are commonly located on the anterolateral wall of the vagina. The cysts tend to be less than 2 cm in size; however, there have been reports of cysts measuring up to 16 cm. These cysts are usually asymptomatic and are routinely found on gynecologic examination. Yet, if this condition is not properly diagnosed, Gartner cysts can lead to infection, bladder dysfunction, abdominal pain, dyspareunia, urinary incontinence, spontaneous hemorrhage, and even malignant transformations. Diagnosis of Gartner cysts is typically made clinically, with magnetic resonance imaging (MRI) commonly used for further characterization of these cysts. This case report explores a scenario in which bladder sonography was used to diagnose a Gartner duct cyst.
- 2 January 2026
- Published by Wiley in Sonography
- Vol. 13 (1)
Bladder Sonography as a Method of Diagnosing Gartner Cysts: A Case Report
Gartner cysts, also referred to as Gartner duct cysts, are congenital urogenital anomalies that result from failure of regression of the Wolffian ducts. These cysts are commonly located on the anterolateral wall of the vagina. The cysts tend to be less than 2 cm in size; however, there have been reports of cysts measuring up to 16 cm. These cysts are usually asymptomatic and are routinely found on gynecologic examination. Yet, if this condition is not properly diagnosed, Gartner cysts can lead to infection, bladder dysfunction, abdominal pain, dyspareunia, urinary incontinence, spontaneous hemorrhage, and even malignant transformations. Diagnosis of Gartner cysts is typically made clinically, with magnetic resonance imaging (MRI) commonly used for further characterization of these cysts. This case report explores a scenario in which bladder sonography was used to diagnose a Gartner duct cyst.
- Open Access
- 23 March 2025
- Published by Elsevier in JFO Open Ophthalmology
- Vol. 10
Optic neuritis induced by Pembrolizumab treatment for recurrent vulvar cancer
- 23 March 2025
- Published by Elsevier in JFO Open Ophthalmology
- Vol. 10
Open AccessOptic neuritis induced by Pembrolizumab treatment for recurrent vulvar cancer
- Open Access
The Immunomodulatory and Antimicrobial Properties of the Vertebrate Ribonuclease A Superfamily
The Ribonuclease A Superfamily is composed of cationic peptides that are secreted by immune cells and epithelial tissues. Although their physiological roles are unclear, several members of the vertebrate Ribonuclease A Superfamily demonstrate antimicrobial and immune modulation activities. The objective of this review is to provide an overview of the published literature on the Ribonuclease A Superfamily with an emphasis on each peptide’s regulation, antimicrobial properties, and immunomodulatory functions. As additional insights emerge regarding the mechanisms in which these ribonucleases eradicate invading pathogens and modulate immune function, these ribonucleases may have the potential to be developed as a novel class of therapeutics for some human diseases.
Open AccessThe Immunomodulatory and Antimicrobial Properties of the Vertebrate Ribonuclease A Superfamily
The Ribonuclease A Superfamily is composed of cationic peptides that are secreted by immune cells and epithelial tissues. Although their physiological roles are unclear, several members of the vertebrate Ribonuclease A Superfamily demonstrate antimicrobial and immune modulation activities. The objective of this review is to provide an overview of the published literature on the Ribonuclease A Superfamily with an emphasis on each peptide’s regulation, antimicrobial properties, and immunomodulatory functions. As additional insights emerge regarding the mechanisms in which these ribonucleases eradicate invading pathogens and modulate immune function, these ribonucleases may have the potential to be developed as a novel class of therapeutics for some human diseases.
- 1 September 2016
- Published by Elsevier in Kidney International
- Vol. 90 (3) , 568-579
Insulin and the phosphatidylinositol 3-kinase signaling pathway regulate Ribonuclease 7 expression in the human urinary tract
- 1 September 2016
- Published by Elsevier in Kidney International
- Vol. 90 (3) , 568-579
Insulin and the phosphatidylinositol 3-kinase signaling pathway regulate Ribonuclease 7 expression in the human urinary tract